Budemide-F1 Respules
Formoterol 20 mcg + Budesonide 1 mg Respules — High-Dose ICS+LABA Combination
| Composition | Formoterol 20 mcg + Budesonide 1 mg per 2 ml respule |
|---|---|
| Dosage Form | Nebulizer Respule |
| Pack Type | Respule Pack |
| Pack Size | 5 x 4 Respules (20) |
| MRP | ₹ 1500 |
| Therapy | G.P. + Gynaecology / Respiratory — Inhaled Corticosteroid (High Dose) + LABA |
| Storage | Store below 25 °C, protected from light. Use immediately after opening foil. |
📱 WhatsApp Enquiry📞 Call: +919041677932
About Budemide-F1 Respules
Budemide-F1 Respules combine Formoterol 20 mcg with the higher-strength Budesonide 1 mg per 2 ml respule — used in moderate-to-severe asthma and COPD requiring a higher anti-inflammatory dose alongside long-acting bronchodilation. The F1 designation indicates the 1 mg Budesonide content (vs the standard combination dose).
Higher ICS doses are required in patients with poorly controlled asthma despite step-3 therapy, in severe persistent asthma phenotypes, and in chronic-stable COPD with frequent exacerbations and recurrent eosinophilic flare-ups. The combination format ensures patients receive both components in every dose, improving adherence over separate inhalers.
Budemide-F1 is manufactured by Trumac Healthcare under WHO-GMP conditions. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a premium respiratory SKU.
Indications
- Moderate-to-severe persistent asthma inadequately controlled on step-3 therapy
- COPD with frequent exacerbations and prominent eosinophilic inflammation
- Severe asthma phenotypes requiring high-dose ICS + LABA
- Step-up therapy from Budemide-F
Mechanism of Action
Formoterol provides 12-hour bronchodilation via β2 receptor activation. The higher 1 mg Budesonide dose achieves stronger glucocorticoid receptor activation in airway tissue, suppressing eosinophilic and lymphocytic inflammation that drives severe asthma and COPD exacerbations.
Dosage & Administration
Adults: 1 respule by nebulisation twice daily. Rinse mouth after each use. Use under physician supervision.
Side Effects
Tremor, palpitations, oral candidiasis, dysphonia. With higher ICS dose: increased risk of systemic glucocorticoid effects (rare at this dose). Hypokalaemia with high LABA doses.
Contraindications & Precautions
Hypersensitivity. Tachyarrhythmias. Severe cardiovascular disease. Untreated respiratory infection. Children < 12 years for this dose.
Storage
Store below 25 °C, protected from light. Use immediately after opening foil.
Budemide-F1 Respules is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →
Frequently Asked Questions
What is Budemide-F1 Respules used for?
Budemide-F1 combines Formoterol 20 mcg with Budesonide 1 mg — for moderate-to-severe persistent asthma and COPD requiring high-dose combined ICS + LABA therapy.
How does Budemide-F1 differ from Budemide-F?
Budemide-F1 contains a higher dose of Budesonide (1 mg) vs the standard combination — used in patients needing stronger anti-inflammatory action.
Is Budemide-F1 available for PCD pharma franchise?
Yes, on monopoly-based PCD pharma franchise and for third-party manufacturing.
How should Budemide-F1 Respules be stored?
Store below 25 °C, protected from light. Use immediately after opening foil.
Is Budemide-F1 WHO-GMP certified?
Yes, manufactured in WHO-GMP and DCGI-compliant facilities.
Related Products
- Budemide-F Respules — Formoterol 20 mcg + Budesonide per 2 ml respule
- Budemide-Forte Respules — Budesonide IP 1 mg / 2 ml per respule
- Budemide-L Respules — Budesonide 0.5 mg + Levosalbutamol per 2 ml respule